# FDA "Breakthrough Drugs": A Trial Testing the Effect of Alternative Language on Public Perceptions

> **NCT02428556** · NA · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 458 (actual)

## Conditions studied

- Prescription Drugs

## Interventions

- **OTHER:** Facts only
- **OTHER:** promising language
- **OTHER:** breakthrough only
- **OTHER:** breakthrough with "may" warning
- **OTHER:** breakthrough with "is" warning

## Key facts

- **NCT ID:** NCT02428556
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 458 (ACTUAL)
- **Last updated:** 2015-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02428556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02428556, "FDA "Breakthrough Drugs": A Trial Testing the Effect of Alternative Language on Public Perceptions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02428556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*